Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients.
Alongi F, Bignardi M, Garassino I, Pentimalli S, Cavina R, Mancosu P, Reggiori G, Poletti A, Ferrari D, Foa P, Bigoni A, Dragonetti A, Salvatori P, Spahiu O, Fogliata A, Cozzi L, Santoro A, Scorsetti M.
Alongi F, et al. Among authors: cozzi l.
Strahlenther Onkol. 2012 Jan;188(1):49-55. doi: 10.1007/s00066-011-0006-y. Epub 2011 Dec 24.
Strahlenther Onkol. 2012.
PMID: 22194030
Clinical Trial.